CORCEPT THERAPEUTICS INC (CORT)
Data as of , from SEC Form 4 filings.
See up to 3 months of CORT. The 7-day demo opens the 1M and 3M ranges and puts CORT on your watchlist.
Start 7-day demoLatest CORT insider trades
About CORCEPT THERAPEUTICS INC (CORT)
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.
- REDWOOD CITY, CA
- 730
- 2004
- XNAS
CORT Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 56 | 454,748 | $52.80M |
| Grant or award | 13 | 101,768 | |
| Option exercise | 38 | 680,228 | |
CORT insider transactions (Form 4)
92172 Form 4 filings on record, the earliest from Oct 1, 2024, newest first. Filing history page 3 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| James N. Wilson | Gift | Common Stock | 4,000 | $0.00 | - | |
 William Guyer - Officer | Option exercise | Common Stock | 11,767 | $21.65 | $255K | |
| William Guyer - Officer | Option exercise | Stock Option (right to buy) | 11,767 | $0.00 | - | |
| William Guyer - Officer | Open-market sale | Common Stock | 11,767 | $36.01 footnote F3 | $424K | |
| ||||||
| G. Leonard Baker Jr. | Open-market purchase | Common Stock | 75,782 | $33.00 footnote F1 | $2.50M | |
| G. Leonard Baker Jr. | Open-market purchase | Common Stock | 24,218 | $33.56 footnote F2 | $813K | |
| ||||||
| James N. Wilson | Gift | Common Stock | 28,000 | $0.00 | - | |
| David L. Mahoney | Option exercise | Common Stock | 30,000 | $5.86 | $176K | |
| David L. Mahoney | Tax withholding / forfeiture | Common Stock | 5,469 | $32.15 | $176K | |
| David L. Mahoney | Gift | Common Stock | 24,531 | $0.00 | - | |
| David L. Mahoney | Other | Common Stock | 24,531 | $0.00 | - | |
| David L. Mahoney | Option exercise | Stock Option (right to buy) | 30,000 | $0.00 | - | |
| William Guyer - Officer | Option exercise | Common Stock | 8,233 | $21.65 | $178K | |
| William Guyer - Officer | Open-market sale | Common Stock | 8,233 | $35.99 footnote F3 | $296K | |
| William Guyer - Officer | Option exercise | Stock Option (right to buy) | 8,233 | $0.00 | - | |
| ||||||
 Joseph Douglas Lyon - Officer | Grant or award | Common Stock | 398 footnote F1 | $35.97 footnote F2 | $14K | |
| Joseph Douglas Lyon - Officer | Grant or award | Common Stock | 398 footnote F4 | $0.00 | - | |
| Joseph Douglas Lyon - Officer | Tax withholding / forfeiture | Common Stock | 89 | $35.97 footnote F6 | $3K | |
| ||||||
 Sean Maduck - Officer | Grant or award | Common Stock | 454 footnote F4 | $0.00 | - | |
| Sean Maduck - Officer | Tax withholding / forfeiture | Common Stock | 110 | $35.97 footnote F6 | $4K | |
| Sean Maduck - Officer | Grant or award | Common Stock | 454 footnote F1 | $35.97 footnote F2 | $16K | |
| ||||||
 Gary Charles Robb - Officer | Grant or award | Common Stock | 499 footnote F1 | $35.97 footnote F2 | $18K | |
| Gary Charles Robb - Officer | Grant or award | Common Stock | 499 footnote F4 | $0.00 | - | |
| Gary Charles Robb - Officer | Tax withholding / forfeiture | Common Stock | 121 | $35.97 footnote F6 | $4K | |
| ||||||
| William Guyer - Officer | Grant or award | Common Stock | 498 footnote F1 | $35.97 footnote F2 | $18K | |
| William Guyer - Officer | Grant or award | Common Stock | 498 footnote F4 | $0.00 | - | |
| ||||||
 Atabak Mokari - Officer | Grant or award | Common Stock | 397 footnote F1 | $35.97 footnote F2 | $14K | |
| Atabak Mokari - Officer | Grant or award | Common Stock | 397 footnote F4 | $0.00 | - | |
| Atabak Mokari - Officer | Tax withholding / forfeiture | Common Stock | 96 | $35.97 footnote F6 | $3K | |
| ||||||
| Joseph Douglas Lyon - Officer | Grant or award | Stock Option (right to buy) | 140,000 | $0.00 | - | |
 Joseph K. Belanoff - Officer | Grant or award | Stock Option (right to buy) | 460,000 | $0.00 | - | |
| Atabak Mokari - Officer | Grant or award | Stock Option (right to buy) | 140,000 | $0.00 | - | |
| Sean Maduck - Officer | Grant or award | Stock Option (right to buy) | 140,000 | $0.00 | - | |
| Hazel Hunt - Officer | Grant or award | Stock Option (right to buy) | 140,000 | $0.00 | - | |
| Gary Charles Robb - Officer | Grant or award | Stock Option (right to buy) | 140,000 | $0.00 | - | |
| William Guyer - Officer | Grant or award | Stock Option (right to buy) | 140,000 | $0.00 | - | |
| James N. Wilson | Option exercise | Common Stock | 100,000 | $3.88 | $388K | |
| James N. Wilson | Tax withholding / forfeiture | Common Stock | 10,636 | $36.48 | $388K | |
| James N. Wilson | Gift | Common Stock | 89,364 | $0.00 | - | |
| James N. Wilson | Other | Common Stock | 89,364 | $0.00 | - | |
| James N. Wilson | Option exercise | Stock option (right to buy) | 100,000 | $0.00 | - | |
| Sean Maduck - Officer | Gift | Common Stock | 20,570 | $0.00 | - | |
| Sean Maduck - Officer | Other | Common Stock | 20,570 | $0.00 | - | |
| Sean Maduck - Officer | Gift | Common Stock | 34,000 | $0.00 | - | |
| Sean Maduck - Officer | Other | Common Stock | 34,000 | $0.00 | - | |
| Hazel Hunt - Officer | Option exercise | Common Stock | 150,000 | $3.88 | $582K | |
| Hazel Hunt - Officer | Tax withholding / forfeiture | Common Stock | 77,968 | $41.31 | $3.22M | |
| Hazel Hunt - Officer | Option exercise | Stock Option (right to buy) | 150,000 | $0.00 | - | |
| William Guyer - Officer | Option exercise | Common Stock | 20,000 | $21.65 | $433K | |
| William Guyer - Officer | Open-market sale | Common Stock | 20,000 | $40.87 footnote F2 | $817K | |
| William Guyer - Officer | Option exercise | Stock option (right to buy) | 20,000 | $0.00 | - | |
| ||||||
| G. Leonard Baker Jr. | Option exercise | Common Stock | 30,000 | $5.86 | $176K | |
| G. Leonard Baker Jr. | Option exercise | Stock Option (Right To Buy) | 30,000 | $0.00 | - | |
| G. Leonard Baker Jr. | Option exercise | Common Stock | 25,000 | $14.08 | $352K | |
| G. Leonard Baker Jr. | Option exercise | Common Stock | 30,000 | $12.13 | $364K | |
| G. Leonard Baker Jr. | Option exercise | Common Stock | 25,000 | $10.50 | $263K | |
| G. Leonard Baker Jr. | Option exercise | Common Stock | 30,000 | $15.15 | $455K | |
| G. Leonard Baker Jr. | Option exercise | Stock Option (Right To Buy) | 30,000 | $0.00 | - | |
| G. Leonard Baker Jr. | Option exercise | Stock Option (Right To Buy) | 30,000 | $0.00 | - | |
| G. Leonard Baker Jr. | Option exercise | Stock Option (Right To Buy) | 25,000 | $0.00 | - | |
| G. Leonard Baker Jr. | Option exercise | Stock Option (Right To Buy) | 25,000 | $0.00 | - | |
| William Guyer - Officer | Option exercise | Common Stock | 20,000 | $21.65 | $433K | |
| William Guyer - Officer | Open-market sale | Common Stock | 20,000 | $35.18 footnote F2 | $704K | |
| William Guyer - Officer | Option exercise | Stock option (right to buy) | 20,000 | $0.00 | - | |
| ||||||
| Gary Charles Robb - Officer | Option exercise | Common Stock | 145,000 | $3.88 | $563K | |
| Gary Charles Robb - Officer | Tax withholding / forfeiture | Common Stock | 80,284 | $83.59 | $6.71M | |
| Gary Charles Robb - Officer | Option exercise | Stock option (right to buy) | 145,000 | $0.00 | - | |
| Joseph K. Belanoff - Officer | Option exercise | Common Stock | 550,000 | $3.88 | $2.13M | |
| Joseph K. Belanoff - Officer | Gift | Common Stock | 243,154 | $0.00 | - | |
| Joseph K. Belanoff - Officer | Tax withholding / forfeiture | Common Stock | 306,846 | $83.59 | $25.65M | |
| Joseph K. Belanoff - Officer | Other | Common Stock | 243,154 | $0.00 | - | |
| Joseph K. Belanoff - Officer | Option exercise | Stock option (right to buy) | 550,000 | $0.00 | - | |
| James N. Wilson | Gift | Common Stock | 400,000 | $0.00 | - | |
| James N. Wilson | Other | Common Stock | 200,000 | $0.00 | - | |
| James N. Wilson | Other | Common Stock | 200,000 | $0.00 | - | |
| William Guyer - Officer | Gift | Common Stock | 5,287 | $0.00 | - | |
| William Guyer - Officer | Other | Common Stock | 5,287 | $0.00 | - | |
| William Guyer - Officer | Open-market sale | Common Stock | 4,500 | $80.90 | $364K | |
| William Guyer - Officer | Option exercise | Common Stock | 20,000 | $21.65 | $433K | |
| William Guyer - Officer | Grant or award | Common Stock | 224 footnote F1 | $79.78 footnote F2 | $18K | |
| William Guyer - Officer | Grant or award | Common Stock | 224 footnote F3 | $0.00 | - | |
| William Guyer - Officer | Gift | Common Stock | 787 | $0.00 | - | |
| William Guyer - Officer | Other | Common Stock | 787 | $0.00 | - | |
| William Guyer - Officer | Open-market sale | Common Stock | 640 | $80.88 | $52K | |
| William Guyer - Officer | Open-market sale | Common Stock | 19,360 | $80.05 footnote F7 | $1.55M | |
| William Guyer - Officer | Option exercise | Stock option (right to buy) | 20,000 | $0.00 | - | |
| ||||||
| Sean Maduck - Officer | Option exercise | Common Stock | 20,000 | $8.27 | $165K | |
| Sean Maduck - Officer | Grant or award | Common Stock | 205 footnote F6 | $0.00 | - | |
| Sean Maduck - Officer | Open-market sale | Common Stock | 20,000 | $79.52 footnote F3 | $1.59M | |
| Sean Maduck - Officer | Grant or award | Common Stock | 205 footnote F4 | $79.78 footnote F5 | $16K | |
| Sean Maduck - Officer | Tax withholding / forfeiture | Common Stock | 135 | $79.78 footnote F8 | $11K | |
| Sean Maduck - Officer | Option exercise | Stock option (right to buy) | 20,000 | $0.00 | - | |
| ||||||
See every CORT filing on record
These pages show the latest 90 of 172 Form 4 filings on record. The 7-day demo shows all 172, and sign-up brings you back to this table.
Item 5.02, 7.01, 9.01
Item 2.02, 7.01, 9.01
Item 8.01, 9.01
Item 8.01
Recent CORT Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Lyon Joseph Douglas | Officer | 10,000 | $1.15M | View on EDGAR | |
| WILSON JAMES N | Director | 30,000 |
CORT insider trading FAQ
What is the latest insider trade for CORT?
CORCEPT THERAPEUTICS INC (CORT) had 28 insider filings in the last 90 days, with the most recent on 2026-10-05. The full record for CORT runs to 172 Form 4 filings, the earliest from 2024-10-01. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying CORT stock?
No insider purchases of CORT were filed in the last 90 days. 2 purchases are on record for this company.
How many insiders are selling CORT stock?
56 insider sales of CORT were filed in the last 90 days, totaling $52.80M.
Where can I see CORT SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects CORT Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Roberto Wandenkolk Vieira view on EDGAR
- - Joseph Douglas Lyon view on EDGAR
- - Sean Maduck view on EDGAR
- - Justin Frederick Gunn view on EDGAR
- - Gary Charles Robb view on EDGAR
- - Roberto Wandenkolk Vieira view on EDGAR
- - Gary Charles Robb view on EDGAR
- - Joseph Douglas Lyon view on EDGAR
- - James N. Wilson view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where CORT's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow CORT with a 7-day demo
- CORT on your watchlist
- Every CORT Form 4 filing on record
- Up to 3 months of CORT price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
